“A Cross-Sectional Observational Study to Establish the Association Between ECOG Performance Status and Age and Administration of Doublet or Triplet Chemotherapy Containing Xeloda® (capecitabine) in Advanced Gastric Cancer Patients”. European Journal of Oncology and Environmental Health 18, no. 4 (June 4, 2014): 173–180. Accessed July 18, 2024. https://mattioli1885journals.com/index.php/EJOEH/article/view/2443.